Homeublituximab

  • TG Therapeutics completes Enrollment for Ublituximab in MS trial

    • August 12, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Latest data on Ublituximab Ph 2 study in MS patients announced at EAN

    • June 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Ph 2 data for Ublituximab shows encouraging efficacy results in RMS patients

    • June 7, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Ph 2 results of Ublituximab (TG-1101) in MS patients announced by TG Therapeutics at AAN 2018

    • April 26, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more